Refine Results
  1. "Taylor & Francis Group"
Formats
  1. Journal Article (667)
  2. Book Section (44)
  3. Meeting Abstract (28)
  4. Conference Paper (9)
  5. Book Whole (2)
Groups
  1. Center for Hematologic Malignancies (176)
  2. Hematologic Oncology, Division of (162)
  3. Survivorship Research (121)
  4. Population Sciences Research Program (97)
  5. Psychiatry and Behavioral Sciences, Department of (94)
  6. Solid Tumor Oncology Division (78)

More Groups

People
  1. Sergio Giralt (26)
  2. Philip Bialer (22)
  3. Andrew Zelenetz (19)
  4. Hani Hassoun (16)
  5. Heather Landau (16)
  6. Martin Tallman (16)

More People

Years
  1. 2020 (15)
  2. 2019 (42)
  3. 2018 (38)
  4. 2017 (41)
  5. 2016 (54)
  6. 2015 (46)

More Years

Publications
  1. Leukemia and Lymphoma (192)
  2. Expert Review of Anticancer Therapy (57)
  3. Journal of Psychosocial Oncology (44)
  4. Women's Oncology Review (35)
  5. Cancer Biology and Therapy (26)
  6. Atlas of Procedures in Breast Cancer Surgery (24)

More Publications

Publishers
  1. Taylor & Francis Group (750)

Results (750)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Checking in with your Document Delivery user base: Creating, implementing, and learning from client satisfaction surveys
    Journal Article

    Larsen, S. C.; Gibson, D. S.
    Medical Reference Services Quarterly (2020)

    Fulltext@MSK | Save
  • Enhancing CAR T cell efficacy: The next step toward a clinical revolution?
    Journal Article

    Namuduri, M.; Brentjens, R. J.
    Expert Review of Hematology (2020)

    Fulltext@MSK | Save
  • ‘Don’t know’ responding and estimates of perceived risk: Failing to provide a ‘don’t know’ response systematically biases laypeople’s perceived risk estimates
    Journal Article

    Kiviniemi, M. T.; Ellis, E. M.; Orom, H.; Waters, E. A.; Hay, J. L.
    Health, Risk and Society (2020)

    Fulltext@MSK | Save
  • Immunotherapy for castration-resistant prostate cancer: Has its time arrived?
    Journal Article

    Slovin, S. F.
    Expert Opinion on Biological Therapy (2020)

    Fulltext@MSK | Save
  • Contralateral prophylactic mastectomy in breast cancer: What to discuss with patients
    Journal Article

    Montagna, G.; Morrow, M.
    Expert Review of Anticancer Therapy (2020)

    Fulltext@MSK | Save
  • Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: A dual-center, propensity score-matched analysis
    Journal Article

    Tremblay, D.; King, A.; Li, L.; Moshier, E.; Coltoff, A.; Koshy, A.; Kremyanskaya, M.; Hoffman, R.; Mauro, M. J.; Rampal, R. K.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: The DASFREE study
    Journal Article

    Shah, N. P.; García-Gutiérrez, V.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Pane, F.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Incidence of infectious complications with the combination of bendamustine and an anti-CD20 monoclonal antibody
    Journal Article

    Sarlo, K. M.; Dixon, B. N.; Ni, A.; Straus, D. J.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Clonally-related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications
    Journal Article

    Kumar, P.; Uppal, M.; Xiao, W.; Dogan, A.; Roshal, M.; Gao, Q.; Aypar, U.; Zhang, Y.; Arcila, M. E.; Moung, C.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Lower adherence: A description of colorectal cancer screening barrier talk
    Journal Article

    Johnson Shen, M.; Elston Lafata, J.; D’Agostino, T. A.; Bylund, C. L.
    Journal of Health Communication (2020)

    Fulltext@MSK | Save